Risk evaluation in pediatric practice aids in prevention of childhood overweight

Barbara A Dennison1, Penny S Boyer

  • 1Columbia University School of Medicine, New York, NY, USA.

Pediatric Annals
|February 26, 2004
PubMed

Insights

Pediatric providers are key to preventing childhood overweight by screening children starting at age 2 using Body Mass Index (BMI). Educating families and addressing biases are crucial for early intervention and healthy weight management.

Area of Science:

  • Pediatric Health
  • Preventive Medicine
  • Public Health

Background:

  • Childhood overweight is a significant public health concern requiring effective primary prevention strategies.
  • Pediatric providers and support staff are essential in identifying and addressing overweight in children.
  • Understanding and rectifying provider biases regarding childhood weight is critical for effective care.

Purpose of the Study:

  • To emphasize the role of pediatric healthcare teams in the primary prevention of childhood overweight.
  • To highlight the importance of early identification of children at risk for overweight.
  • To outline the necessary knowledge and support for office staff in managing pediatric weight status.

Main Methods:

  • Utilizing Body Mass Index (BMI) as the standard screening tool for pediatric weight status from age 2.
  • Educating pediatric office staff on BMI application and sensitive communication with parents.
  • Integrating age-appropriate anticipatory guidance into well-child visits for families.

Main Results:

  • Early recognition of predisposed children is vital for preventing overweight.
  • Standardized screening with BMI beginning at age 2 is recommended.
  • Staff knowledge and supportive office environments enhance prevention efforts.

Conclusions:

  • Pediatric providers and staff are pivotal in primary prevention of childhood overweight.
  • Accurate BMI screening and sensitive parental counseling are essential components of care.
  • Proactive anticipatory guidance during well-child visits empowers families in preventing childhood overweight.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...